Sign In
Buy GMED
$86.15
+3.80 (+4.61%)
At Close: Aug 10, 2026
Will Globus Medical (GMED) Beat Estimates Again in Its Next Earnings Report?
01:15pm, Friday, 18'th Apr 2025
Globus Medical (GMED) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Globus Medical Schedules First Quarter Earnings Release and Conference Call
04:30pm, Thursday, 17'th Apr 2025
AUDUBON, Pa., April 17, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal technology company, will announce its financial results for the first quarter ended March 3
International Growth Drives GMED Stock Amid Fierce Competition
01:20pm, Monday, 14'th Apr 2025
Globus Medical is gearing up for a series of product launches throughout the Musculoskeletal portfolio in the coming months of 2025.
GMED Stock May Benefit Following the Acquisition of Nevro
09:40am, Monday, 07'th Apr 2025
Globus Medical acquires Nevro Corp. to expand its presence in the $2.50 billion musculoskeletal market.
Globus Medical completes acquisition of Nevro Corp.
08:31am, Thursday, 03'rd Apr 2025
AUDUBON, Pa., April 03, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced the completion of its previously disclosed acquisitio
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of N
GMED Stock Jumps 41.8% in a Year: What's Behind the Rally?
09:25am, Friday, 21'st Mar 2025
Globus Medical's robust musculoskeletal offerings and synergies from the NuVasive merger are fueling its stock gains.
Should You Hold Globus Medical Stock in Your Portfolio Now?
11:05am, Wednesday, 19'th Mar 2025
GMED stays on investors' radar due to its high NuVasive-merger synergies and solid Musculoskeletal prospects.
New Product Launches Benefit GMED Stock Amid Macro Issues
12:30pm, Tuesday, 18'th Mar 2025
Globus Medical currently awaits a strong cadence of product launches throughout the Musculoskeletal portfolio in the coming months of 2025.
Globus Medical Expands Anterior Spine Portfolio With Two New Offerings
10:12am, Friday, 14'th Mar 2025
GMED announces the commercial launch of COHERE ALIF Spacer and Modulus ALIF Blades.
AUDUBON, Pa., March 11, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced two commercial launches: COHERE™ ALIF Spacer: The
Globus Medical to feature ExcelsiusFlex™ for Total Knee Arthroplasty at the American Academy of Orthopedic Surgeons Annual Meeting
04:40pm, Thursday, 06'th Mar 2025
AUDUBON, Pa., March 06, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced it will participate in the 2025 Annual Meeting of the
Globus Medical to participate in the Canaccord Genuity 2025 Musculoskeletal Conference
07:01pm, Wednesday, 05'th Mar 2025
AUDUBON, Pa., March 05, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced it is scheduled to participate in the Canaccord Genuit
Is the Options Market Predicting a Spike in Globus Medical (GMED) Stock?
10:15am, Wednesday, 05'th Mar 2025
Investors need to pay close attention to Globus Medical (GMED) stock based on the movements in the options market lately.
Nevro Reports Fourth-Quarter and Full-Year 2024 Financial Results
04:15pm, Tuesday, 04'th Mar 2025
REDWOOD CITY, Calif. , March 4, 2025 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pa
